Study Comparing Intranasal Powder Formulation of Ondansetron Demonstrates Comparable Pharmacokinetic Profile to Intravenous Ondansetron in Animal ...

Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment ...

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings. Interested investors should contact their respective representatives at the sponsoring institutions to request meetings. About ...

Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recent Phase 2 topline results demonstrate NS002’s potential for best-in-class epinephrine delivery, with statistically significant improvements in early absorption compared to EpiPen®; pivotal study ...

Nasus is a late bloomer in League of Legends. The champion can be one of the most powerful tanks in the game if players use him correctly. Gamers need to take a conservative approach in the first five ...

After Sivir, Rammus and Garen, Nasus, the Curator of the Sands, is the next champion to get a visual update and an Infernal skin as an addition. Riot continues visually updating old champions. Nasus, ...

Number-fact #1: there are 116 champions in League of Legends today, and plenty more to come. Number-fact #2: there are 365 days in a year, and the character models in this four year old game look a ...

Everyone hates Nasus at one point or other. Even Nasus players hate playing against Nasus. Why? Because he is pure, high-octane bullshit that can 1v5 your entire team if you let him just do his job.